These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19773258)

  • 21. The R2464C missense mutation in the von Willebrand factor gene causes a novel abnormality of multimer electrophoretic mobility and falls into the subgroup of type 2 von Willebrand disease 'unclassified'.
    Lester WA; Guilliatt AM; Enayat MS; Rose P; Hill FG
    Thromb Haemost; 2007 Jan; 97(1):159-60. PubMed ID: 17200787
    [No Abstract]   [Full Text] [Related]  

  • 22. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
    Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The molecular basis of von Willebrand disease.
    Mohlke KL; Nichols WC; Ginsburg D
    Int J Clin Lab Res; 1999; 29(1):1-7. PubMed ID: 10356656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression studies of missense mutations p.D141Y, p.C275S located in the propeptide of von Willebrand factor in patients with type 3 von Willebrand disease.
    Baronciani L; Federici AB; Cozzi G; La Marca S; Punzo M; Rubini V; Canciani MT; Mannucci PM
    Haemophilia; 2008 May; 14(3):549-55. PubMed ID: 18328061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease.
    O'Brien LA; James PD; Othman M; Berber E; Cameron C; Notley CR; Hegadorn CA; Sutherland JJ; Hough C; Rivard GE; O'Shaunessey D; Lillicrap D;
    Blood; 2003 Jul; 102(2):549-57. PubMed ID: 12649144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van Vliet HH
    Acta Haematol; 2009; 121(2-3):85-97. PubMed ID: 19506353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factor.
    Hilbert L; Fressinaud E; Ribba AS; Meyer D; Mazurier C;
    Thromb Haemost; 2002 Apr; 87(4):635-40. PubMed ID: 12008946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M
    Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the mutant von Willebrand factor gene in von Willebrand disease.
    Zhang Z; Lindstedt M; Blombäck M; Anvret M
    Hum Genet; 1995 Oct; 96(4):388-94. PubMed ID: 7557958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in severe, type III von Willebrand's disease in the Dutch population: candidate missense and nonsense mutations associated with reduced levels of von Willebrand factor messenger RNA.
    Eikenboom JC; Ploos van Amstel HK; Reitsma PH; Briët E
    Thromb Haemost; 1992 Oct; 68(4):448-54. PubMed ID: 1448779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges in diagnosis of von Willebrand disease in the presence of combined mutations of different genes.
    Nava T; Dubé E; Gauthier J; Vézina C; Bonnefoy A; Lillicrap D; Rivard GE
    Haemophilia; 2019 Mar; 25(2):e113-e117. PubMed ID: 30690834
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification of mutations in the canine von Willebrand factor gene associated with type III von Willebrand disease.
    Rieger M; Schwarz HP; Turecek PL; Dorner F; van Mourik JA; Mannhalter C
    Thromb Haemost; 1998 Aug; 80(2):332-7. PubMed ID: 9716162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The spectrum of mutations in Southern Spanish patients with von Willebrand disease.
    Álvarez-Laderas I; Núñez R; Jiménez-Bárcenas R; Rodriguez Martorell FJ; Garcia-Lozano JR; de Cos C; Pérez Garrido R
    Haemophilia; 2015 May; 21(3):e240-e242. PubMed ID: 25689060
    [No Abstract]   [Full Text] [Related]  

  • 35. The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factor.
    Kroner PA; Foster PA; Fahs SA; Montgomery RR
    Blood; 1996 Feb; 87(3):1013-21. PubMed ID: 8562925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
    Michiels JJ; van Vliet HH
    Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: an elusive phenotype and a difficult diagnosis.
    Casonato A; Sartorello F; Pontara E; Gallinaro L; Bertomoro A; Grazia Cattini M; Daidone V; Szukowska M; Pagnan A
    Thromb Haemost; 2007 Dec; 98(6):1182-7. PubMed ID: 18064311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the von Willebrand factor gene (VWF) in von Willebrand disease type III patients from 24 families of Swedish and Finnish origin.
    Zhang ZP; Blombäck M; Egberg N; Falk G; Anvret M
    Genomics; 1994 May; 21(1):188-93. PubMed ID: 8088787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular study of VWF gene from Mexican Mestizo patients with von Willebrand disease, and the finding of three new mutations.
    Melo-Nava BM; Benítez H; Palacios JJ; Nieva B; Arenas D; Jaloma-Cruz AR; Navarrete C; Salamanca F; Peñaloza R
    Blood Cells Mol Dis; 2007; 39(3):361-5. PubMed ID: 17681836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Arg545----Cys545 substitution mutation of the von Willebrand factor in type IIB von Willebrand's disease.
    Donnér M; Andersson AM; Kristoffersson AC; Nilsson IM; Dahlbäck B; Holmberg L
    Eur J Haematol; 1991 Nov; 47(5):342-5. PubMed ID: 1761120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.